Author:
Qu Qi,Liu Limin,Zhang Yanming,Li Xiaoli,Wu Depei
Funder
Jiangsu Provincial Special Program of Medical Science
Jiangsu Province's Key Medical Center
Priority Academic Program Development of Jiangsu Higher Education Institution
National Public Health Grand Research Foundation
National High-tech R&D Program
National Science Foundation of China
Subject
Cancer Research,Oncology,Hematology
Reference25 articles.
1. Novel agents and regimens for acute myeloid leukemia: 2009 ASH annual meeting highlights;Zhu;J. Hematol. Oncol.,2010
2. Prognostic factors and outcomes of adult patients with acute myeloid leukemia after first relapse;Kurosawa;Haematologica,2010
3. Concurrent use of granulocyte colony-stimulating factor with low-dose cytosine arabinoside and aclarubicin for previously treated acute myelogenous leukemia: a pilot study;Yamada;Leukemia,1995
4. A meta-analysis of CAG (cytarabine, aclarubicin, G-CSF) regimen for the treatment of 1029 patients with acute myeloid leukemia and myelodysplastic syndrome;Wei;J. Hematol. Oncol.,2011
5. Low-dose cytarabine, aclarubicin and granulocyte colony-stimulating factor priming regimen versus idarubicin plus cytarabine regimen as induction therapy for older patients with acute myeloid leukemia;Jin;Leukemia Lymphoma,2014
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献